de Thé H - Search Results

1

de Thé H. de Thé H. Nat Rev Cancer. 2018 Feb;18(2):117-127. doi: 10.1038/nrc.2017.103. Epub 2017 Dec 1. Nat Rev Cancer. 2018. PMID: 29192213 Review.

2

Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic-resistant NB4 cells.

Giannì M, Koken MH, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z, de Thé H. Giannì M, et al. Among authors: de the h. Blood. 1998 Jun 1;91(11):4300-10. Blood. 1998. PMID: 9596679 Free article.

3

[Arsenic and retinoic acid, towards targeted treatments of acute promyelocytic leukemia?].

de Thé H. de Thé H. Bull Acad Natl Med. 1998;182(1):63-71. Bull Acad Natl Med. 1998. PMID: 9622932 Review. French.

4

PML induces a novel caspase-independent death process.

Quignon F, De Bels F, Koken M, Feunteun J, Ameisen JC, de Thé H. Quignon F, et al. Among authors: de the h, de bels f. Nat Genet. 1998 Nov;20(3):259-65. doi: 10.1038/3068. Nat Genet. 1998. PMID: 9806544

5

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.

Koken MH, Daniel MT, Gianni M, Zelent A, Licht J, Buzyn A, Minard P, Degos L, Varet B, de Thé H. Koken MH, et al. Among authors: de the h. Oncogene. 1999 Jan 28;18(4):1113-8. doi: 10.1038/sj.onc.1202414. Oncogene. 1999. PMID: 10023688

6

How acute promyelocytic leukaemia revived arsenic.

Zhu J, Chen Z, Lallemand-Breitenbach V, de Thé H. Zhu J, et al. Among authors: de the h. Nat Rev Cancer. 2002 Sep;2(9):705-13. doi: 10.1038/nrc887. Nat Rev Cancer. 2002. PMID: 12209159 Review.

7

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia.

Guillemin MC, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V, Zhu J, Janin A, Daniel MT, Gourmel B, Degos L, Dombret H, Lanotte M, De Thé H. Guillemin MC, et al. Among authors: de the h. J Exp Med. 2002 Nov 18;196(10):1373-80. doi: 10.1084/jem.20021129. J Exp Med. 2002. PMID: 12438428 Free PMC article.

8

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Raffoux E, Rousselot P, Poupon J, Daniel MT, Cassinat B, Delarue R, Taksin AL, Réa D, Buzyn A, Tibi A, Lebbé G, Cimerman P, Chomienne C, Fermand JP, de Thé H, Degos L, Hermine O, Dombret H. Raffoux E, et al. Among authors: de the h. J Clin Oncol. 2003 Jun 15;21(12):2326-34. doi: 10.1200/JCO.2003.01.149. J Clin Oncol. 2003. PMID: 12805334 Clinical Trial.

9

A sumoylation site in PML/RARA is essential for leukemic transformation.

Zhu J, Zhou J, Peres L, Riaucoux F, Honoré N, Kogan S, de Thé H. Zhu J, et al. Among authors: de the h. Cancer Cell. 2005 Feb;7(2):143-53. doi: 10.1016/j.ccr.2005.01.005. Cancer Cell. 2005. PMID: 15710327 Free article.

10

Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia.

Lallemand-Breitenbach V, Zhu J, Kogan S, Chen Z, de Thé H. Lallemand-Breitenbach V, et al. Among authors: de the h. Nat Rev Cancer. 2005 Oct;5(10):821-7. doi: 10.1038/nrc1719. Nat Rev Cancer. 2005. PMID: 16175176 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page